Welcome to our dedicated page for Scansource SEC filings (Ticker: SCSC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission (SEC) filings for ScanSource, Inc. (NASDAQ: SCSC), a hybrid technology distributor in the wholesale trade sector. Through these filings, investors can review the company’s official disclosures on financial performance, governance, risk factors and significant corporate events.
ScanSource files annual reports on Form 10-K and quarterly reports on Form 10-Q, which detail its operations across the Specialty Technology Solutions and Intelisys & Advisory segments, along with information on net sales, gross profit, operating income, net income and liquidity. These reports also discuss the role of recurring revenue, non-GAAP metrics such as Adjusted EBITDA, Adjusted ROIC, free cash flow and net debt, and provide reconciliations to GAAP measures.
Current reports on Form 8-K document material events, including earnings announcements, share repurchase authorizations, acquisitions, changes in auditor and other significant developments. For example, recent 8-K and 8-K/A filings describe the Audit Committee’s decision to dismiss Grant Thornton LLP as independent registered public accounting firm and to appoint Deloitte & Touche LLP, as well as the furnishing of earnings press releases and earnings infographics.
The definitive proxy statement on Form DEF 14A offers insight into ScanSource’s corporate governance, Board composition, executive compensation and strategic priorities. It also includes commentary from management on performance, capital allocation, recurring revenue, margin expansion and long-term goals.
On Stock Titan, SEC filings for SCSC are updated in near real time from EDGAR and are paired with AI-powered summaries that explain key points in accessible language. These summaries help readers quickly understand complex sections of 10-Ks, 10-Qs, 8-Ks and proxy statements, while links to full documents allow for deeper review. Users can also monitor exhibits and other disclosures that relate to auditor changes, shareholder meetings and non-GAAP financial information.
ScanSource, Inc. reported slightly higher revenue but mixed profit trends for the quarter and six months ended December 31, 2025. Quarterly net sales were $766.5 million, up from $747.5 million a year earlier, while net income edged down to $16.5 million from $17.1 million, with diluted EPS at $0.75 versus $0.70.
For the first six months, net sales were $1.51 billion compared with $1.52 billion, but net income rose to $36.4 million from $34.0 million, and diluted EPS increased to $1.63 from $1.39, helped by better gross margins and lower restructuring costs. Operating cash flow strengthened to $54.1 million from $38.6 million, supporting continued share repurchases and the October 2025 acquisition of DataXoom, which added goodwill and intangible assets.
ScanSource entered a new five-year credit agreement in December 2025, providing a $400 million multicurrency revolving facility and a $100 million term loan, and reduced total debt to $102.7 million from $136.1 million. Management highlights ongoing macroeconomic uncertainty, including inflation, tariffs and foreign exchange volatility, and is assessing the impact of new U.S. tax legislation enacted in 2025.
ScanSource, Inc. furnished an update on its recent financial and governance developments. The company issued a press release announcing financial results for its second quarter ended December 31, 2025, along with an unaudited earnings infographic, both of which are available as exhibits and on its website.
The filing also details Board leadership changes. Charles A. Mathis has been appointed Lead Independent Director and Chair of the Nominating and Corporate Governance Committee, succeeding Peter C. Browning, who remains on the Board and all its committees. Vernon J. Nagel succeeds Mr. Mathis as Chair of the Audit Committee.
A ScanSource, Inc. insider who is a director and officer serving as CEO, President and board chair reported multiple sales of company common stock. The Form 4 shows total sales of 20,000 shares of ScanSource common stock in transactions dated December 12, 15 and 16, 2025, all coded as sales.
Reported weighted average sale prices include 9,459 shares at $40.81 per share on December 15, 2025 and 7,281 shares at $41.53 per share on December 16, 2025, with additional smaller sales at other disclosed prices. After these transactions, the insider directly beneficially owns 182,512 shares of ScanSource common stock.
ScanSource, Inc. reported an insider stock transaction by its SEVP & CFO. On 12/11/2025, the officer sold 5,020 shares of ScanSource common stock in an open-market transaction coded "S" at a weighted average price of $42.30 per share.
After this sale, the insider directly owned 83,326 shares of ScanSource common stock. The reported weighted average price reflects multiple trades executed at prices ranging from $42.02 to $42.57 per share.
ScanSource, Inc. filed an 8-K/A confirming a planned change in independent auditors. The Audit Committee approved the transition after a competitive process on October 9, 2025. Grant Thornton LLP was dismissed effective November 6, 2025, immediately after the company filed its Form 10-Q for the quarter ended September 30, 2025. Deloitte & Touche LLP’s engagement began November 6, 2025 for the fiscal year ending June 30, 2026 and related interim periods commencing after September 30, 2025.
Grant Thornton’s audit reports for the fiscal years ended June 30, 2025 and June 30, 2024 contained no adverse opinion, disclaimer, or qualification as to uncertainty, audit scope, or accounting principles. The company reports no disagreements or reportable events with Grant Thornton through November 6, 2025. Grant Thornton’s concurrence letter is filed as Exhibit 16.1.
ScanSource, Inc. furnished an update on its first-quarter results for the period ended September 30, 2025. The company issued a press release and an earnings infographic, which are provided as Exhibits 99.1 and 99.2 and available on its website.
The materials are unaudited and are being furnished, not filed, under the Exchange Act. ScanSource also noted that an updated investor presentation will be posted on its website within approximately two weeks.
ScanSource (SCSC) reported Q1 FY2026 results for the quarter ended September 30, 2025. Net sales were $739.7 million (down 4.6% year over year), while net income rose to $19.9 million from $17.0 million. Diluted EPS was $0.89 versus $0.69 a year ago as improved margins and lower non-operating expenses offset lower revenue. Gross profit increased to $107.5 million, lifting gross margin to 14.5% from 13.1%.
By segment, Specialty Technology Solutions sales were $715.4 million (down 4.9%) with margin expansion to 11.7%, aided by favorable supplier program recognition and mix. Intelisys & Advisory sales were $24.2 million (up 4.0%), reflecting an acquisition; Intelisys net billings grew 1.7%. Operating income improved to $25.9 million from $17.6 million as prior-year restructuring did not recur. Cash from operations was $23.2 million; the company repurchased $21.3 million of stock. Total debt was $133.9 million with $350.0 million revolver availability, and the company was in covenant compliance. Subsequent event: acquisition of DataXoom on October 20, 2025.
ScanSource (SCSC) filed its annual report outlining a two-segment structure and steady scale. For the fiscal year ended June 30, 2025, net sales were $3.04 billion. Effective July 1, 2024, the company realigned to two operating segments: Specialty Technology Solutions (wholesale/resale model for hardware, SaaS and subscription services across mobility, POS, security, networking and communications) and Intelisys & Advisory (agency model distributing connectivity, cloud and next‑gen technologies and advisory services).
ScanSource serves ~25,000 channel sales partners with offerings from ~500 suppliers. Two suppliers—Cisco and Zebra—each represented more than 10% of fiscal 2025 net sales, highlighting supplier concentration risk. International operations contributed 7.9% of revenue, primarily in Brazil. The company reported approximately 2,100 employees, a central North American distribution center in Southaven, MS (741,000 sq. ft.), and continued investment in cybersecurity after a May 2023 ransomware incident. As of August 18, 2025, common shares outstanding were 21,884,508. The report details credit exposure, supply chain, competition and liquidity risks alongside a focus on operational excellence and partner enablement.
ScanSource, Inc. filed its definitive proxy for the 2025 Annual Meeting, outlining fiscal 2025 performance and governance items for shareholder vote. Net sales were just over $3 billion, down 6.7%, while gross profits rose to $408.6 million (up 2.4%) and adjusted EBITDA reached $144.7 million (up 2.8%). Gross margin improved to 13.4% and adjusted EBITDA margin to 4.76%. Non-GAAP net income was $85.1 million (up 9.6%) and free cash flow was $104 million, aided by $106.5 million in share repurchases. Recurring revenue contributed 32.8% of consolidated gross profits versus 27.5% last year; adjusted ROIC rose to 13.6%.
The company ended fiscal 2025 with $126 million in cash, $112.3 million in operating cash flow and $104.1 million in free cash flow. August 2024 acquisitions of Resourcive and Advantix were accretive to non-GAAP EPS and adjusted ROIC. The Annual Meeting is set for December 9, 2025 at 9:00 a.m. EST. Shareholders will vote to elect eight directors, approve NEO compensation on an advisory basis, and ratify Deloitte & Touche LLP as auditor for fiscal 2026 following a competitive process; Grant Thornton was dismissed after completing the Q1 FY2026 review. The record date is October 3, 2025 with 22,067,128 shares entitled to vote.
ScanSource, Inc. announced an auditor transition. Following a competitive process, the Audit Committee approved the dismissal of Grant Thornton LLP as independent registered public accounting firm, effective upon completion of the interim review of the Form 10-Q for the three months ended September 30, 2025. Grant Thornton was notified on October 10, 2025.
The Committee appointed Deloitte & Touche LLP as the new independent auditor for the fiscal year ending June 30, 2026 and related interim periods commencing after September 30, 2025, subject to completion of standard client acceptance procedures and an engagement letter. ScanSource reports that Grant Thornton’s audit opinions for fiscal 2024 and 2025 were unmodified and there were no disagreements or reportable events through October 9, 2025. Grant Thornton’s concurrence letter, dated October 16, 2025, is filed as Exhibit 16.1.
FAQ
What is the current stock price of Scansource (SCSC)?
What is the market cap of Scansource (SCSC)?
